Desperate Couples are Misled by Only Positive Reports of IVF
By Connie St Louis,
The Conversation
| 11. 14. 2013
Reflecting on her imminent departure as head of the Human Fertilisation and Embryology Authority, the body that regulates IVF and fertility services, Lisa Jardine said
in an interview last week that “nobody wants to run stories about the people who go through IVF for nothing.” She’s right.
There’s a paucity of stories about couples that have been through the IVF treadmill and still remain childless (or fertility treatments that
don’t work for most). Hardly anyone bears witness to the spiralling cost of IVF treatment and the enormous sacrifices that couples are prepared to make. When did you last see a TV medical documentary that showed the gruelling failed treatments that cost thousands, and coupled with debt from having to remortgage? Or a final haunting shot of a beautifully decorated but uninhabited child’s nursery?
Instead, as Jardine said: “The stories are always exciting. The stories about multiple births are always about beautiful babies.” These stories often go hand-in-hand with has been described as a “cycle of hype”. Headline after headline promise hope, which also parades “success rates that the industry...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...